B-cell Non-Hodgkin Lymphoma (B-NHL) research hub

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

This study is looking at a new medicine called odronextamab for adults with a type of blood cancer called B-cell non-Hodgkin lymphoma. Researchers want to see how well it works to fight the cancer and if it's safe for patients who have already tried other treatments.